Last Price$5.03Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 7/16/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$4.99 (100)
Ask (Size)$5.12 (200)
Day Low / HighN/A - N/A

Read more news Recent News

--Analyst Actions: Oppenheimer Downgrades HEXO to Perform From Outperform, Sets $7 PT on 'Potential for Pricing Pressures,' Notes Stock Up 63% YTD
10:13AM ET 6/25/2019 MT Newswires

Price: 5.22, Change: -0.14, Percent Change: -2.70 ...

Market Chatter: Molson Coors and HEXO JV to Begin Selling Cannabis-Infused Drinks in Canada in December
6:03AM ET 6/18/2019 MT Newswires

Molson Coors (TAP, TAP.A) and HEXO Corp. (HEXO) have teamed up to produce a variety of non-alcoholic, cannabis-infused drinks for the Canadian market which...

Wall Street Sees Positive Start, Oil Rise as Mid-East Tensions Brew After Tanker Incident
9:09AM ET 6/13/2019 MT Newswires

US stocks were set for moderate gains Thursday despite fresh geopolitical tensions, including a tanker incident near the Persian Gulf which propped up oil...

HEXO Corp. Affiliate Secures Medical Cannabis License in Greece
7:07AM ET 6/13/2019 MT Newswires

HEXO Corp. (HEXO) said pre-market Thursday that its affiliate, HEXO MED S.A., has obtained a medical cannabis installation license that will allow the...

View all Commentary and Analysis

Cannabis 3.0 With Dooma Wendschuh, Province Brands
7:37AM ET 7/17/2019 Seeking Alpha

CannTrust: What A Mess
9:31AM ET 7/10/2019 Seeking Alpha

HEXO: Weak Quarter Could Delay Its Ambitious Revenue Goal
8:36PM ET 7/01/2019 Seeking Alpha

Weekly Cannabis Report: Pot Prices Will Start Falling In Canada
1:30PM ET 7/01/2019 Seeking Alpha

Company Profile

Business DescriptionHEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on August 13, 2013 and is headquartered in Gatineau, Canada. View company web site for more details
Address490 Boulevard Saint-Joseph
Gatineau, Québec J8Y 3Y7
Number of EmployeesN/A
President, Chief Executive Officer & DirectorSébastien St. Louis
Chief Operating OfficerDonald J. Courtney
Chief Financial OfficerMichael P. Monahan
Director & Medical DirectorMichael Munzar

Company Highlights

Price Open$5.14
Previous Close$5.03
52 Week Range$3.02 - 8.40
Market Capitalization$1.3 B
Shares Outstanding256.9 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement09/12/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.22
Beta vs. S&P 500N/A
Revenue$3.9 M
Net Profit Margin-106.55%
Return on Equity-9.21%

Analyst Ratings as of 07/05/2019

Consensus RecommendationConsensus Icon
Powered by Factset